Prostate cancer is the second leading cause of cancer death in American men, behind lung cancer. About 1 in 9 men will be diagnosed with prostate cancer during his lifetime, and about 1 man in 41 will die of prostate cancer.
There are many treatment options for prostate cancer, and it is important that patients know what to expect from each option. It's equally important that patients are provided support after treatment as they start a new cancer-free life. This sailing event will raise money for services that provide patients with the knowledge needed to make the best decisions around treatment for their prostate cancer, and will ensure that survivors have access to post-procedure support.
About Rich Stearns:
Two years ago, Rich was diagnosed with prostate cancer and sought care at the University of Chicago Medicine on the recommendation of a fellow sailor. Rich is the owner of Stearns Boating LLC, the J-Boat, Dehler, Hanse, and Nautor Swan dealer for the Midwest. He has been racing sailboats since 1962—participating in three Olympic Solo Sailing Campaigns, raced Chicago to Mackinac 44 times finishing 1st overall five times, and a record breaking run in 1987. Learn more about Rich’s impressive and extensive sailing experiences on his website. Rich also wrote the bestselling book, "Getting Started in Sailboat Racing."
Please support this race so we can ensure that all prostate cancer survivors are able to make informed treatment decisions!
22nd Running of the Solo Chicago Mackinac Challenge:
- When: June 22, 2018
- Where: 330 miles nonstop race from Chicago to Mackinac Island—between 55 and 80 hours of racing
- What: 27 boats of all sizes
Make a gift in Honor of Rich Stearns’ Race to Mackinac:
About the University of Chicago Medicine Prostate Cancer Program:
The University of Chicago Medicine’s Prostate Cancer experts are part of a multi-disciplinary team focused on attacking cancer through laboratory research, clinical trials, and prevention research. Our nationally recognized surgeons and scientists are leading research and offering the latest therapies to patients.
A gift to the Prostate Cancer Program at the University of Chicago Medicine will continue to drive innovative work—ultimately continuing to make leaps that translate into substantial improvements in men’s health and lives. Thank you for your generous support of this race and the prostate cancer initiatives of the University of Chicago Medicine!